A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002) (NCT07300267)
A Phase 1, Randomized, Double-Blind, Active Comparator Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Novel Pneumococcal Vaccine in Children
🩺 Plain-English Summary (8th-Grade Level)
Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria. This study will look at V118C in toddlers and infants. The goal of the study is to learn how safe V118C is for children and how well they tolerate it.
Who can join: Review the eligibility criteria below.
Location: Madera Family Medical Group ( Site 1004) — Madera, California
Age range: 2 Months to 15 Months
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- Madera Family Medical Group ( Site 1004) — Madera, California
- Acevedo Clinical Research Associates ( Site 1029) — Miami, Florida
- University of South Florida-Department of Pediatrics ( Site 1002) — Tampa, Florida
- Cotton O'Neil Research Center ( Site 1039) — Topeka, Kansas
- University of Louisville, Norton Children's Research Institute ( Site 1005) — Louisville, Kentucky
- The Pediatric Center ( Site 1025) — Columbia, Maryland
- Saint Louis University Center for Vaccine Development ( Site 1031) — St Louis, Missouri
- Child Health Care Associates ( Site 1035) — East Syracuse, New York
- Tribe Clinical Research, LLC-Pediatrics ( Site 1008) — Greenville, South Carolina
- Tribe Clinical Research - Spartanburg ( Site 1001) — Spartanburg, South Carolina
- Epic Medical Research - Carrollton ( Site 1038) — Carrollton, Texas
- Epic Medical Research- Garland ( Site 1017) — Garland, Texas
- University of Texas Medical Branch ( Site 1020) — League City, Texas
- Pediatric Research of Charlottesville, LLC ( Site 1012) — Charlottesville, Virginia
📞 Contact the Study Coordinator
Phone: (888) 577-8839
Email: Trialsites@msd.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Pneumococcal Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.